ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø ´ëÇѳúÁ¹ÁßÇÐȸ 2019³â 6¿ù ¿µÈ£³² ³úÁ¹Áß º¸¼ö±³À° : 2019-06-29±³À°ÀÏÀÚ : 2019-06-29
±³À°Àå¼Ò : ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
2019³â 6¿ù ¿µÈ£³² ³úÁ¹Áß º¸¼ö±³À° ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê¿ï»ê°æ³²Áöȸ
´ã´çÀÚ : ¾çÅÂÀÏ
¿¬¶ôó : 051-7392-2341
À̸ÞÀÏ :
yangti@hanmail.net ±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 4 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 06-29 ´ë°´ç 12:30~13:00 Registration ()
±âŸ 06-29 ´ë°´ç 13:00~13:10 Opening remark ¼º»ó¹Î, ¼Õ¼ºÀÏ, ½Åº´¼ö(ºÎ¿ï°æ ³úÁ¹ÁßÇÐȸÀå(¼º»ó¹Î), ´ë±¸°æºÏ³úÁ¹ÁßÁöȸÀå(¼Õ¼ºÀÏ), È£³²³úÁ¹Áß¿¬±¸È¸Àå(½Åº´¼ö))
±³À°½Ã°£ 06-29 ´ë°´ç 13:10~13:30 Neuroimages of hyperacute stroke ȲÀçÃá(Ä¥°î°æºÏ´ëº´¿ø)
±³À°½Ã°£ 06-29 ´ë°´ç 13:30~13:50 IV thrombolysis and endovascular treatment of ischemic stroke ¾È¼ºÈ¯(Á¶¼±´ëº´¿ø)
±³À°½Ã°£ 06-29 ´ë°´ç 13:50~14:10 Recent treatment strategy of hemorrhagic stroke Á¤ÁøÇå(µ¿¾Æ´ëº´¿ø)
±³À°½Ã°£ 06-29 ´ë°´ç 14:10~14:20 Q&A ()
ÈÞ½Ä 06-29 ´ë°´ç 14:20~14:40 Coffee Break ()
±³À°½Ã°£ 06-29 ´ë°´ç 14:40~15:05 The essentials in neurocritical care È«Á¤È£(°è¸í´ëµ¿»êº´¿ø)
±³À°½Ã°£ 06-29 ´ë°´ç 15:05~15:30 Advanced practice in neurocritical care ¾È¼ºÈ£(¾ç»êºÎ»ê´ëº´¿ø)
Åä·Ð 06-29 ´ë°´ç 15:30~15:50 Panel Discussion and Q&A ±è¸í±¹, ÃÖÇѳª, µµ¿µ·Ï(°í½Å´ëº´¿ø(±è¸í±¹), ´ë±¸ÆÄƼ¸¶º´¿ø(ÃÖÇѳª), ´ë±¸°¡Å縯´ëº´¿ø(µµ¿µ·Ï))
±³À°½Ã°£ 06-29 ¼¼¹Ì³ª½ÇA 15:50~16:10 Stroke etiology and acute stroke complications °Çö±¸(ÀüºÏ´ëº´¿ø)
±³À°½Ã°£ 06-29 ¼¼¹Ì³ª½ÇA 16:10~16:30 QI issues for stroke center ÀÌÀºÁö(°æºÏ´ëº´¿ø)
±³À°½Ã°£ 06-29 ¼¼¹Ì³ª½ÇA 16:30~16:50 Palliative care for stroke patients and families in stroke unit ±èÇö¹Î(ºÎ»ê¹éº´¿ø)
±³À°½Ã°£ 06-29 ¼¼¹Ì³ª½ÇA 16:50~17:00 Q&A ()
ÈÞ½Ä 06-29 ¼¼¹Ì³ª½ÇA 17:00~17:20 Coffee Break ()
±³À°½Ã°£ 06-29 ¼¼¹Ì³ª½ÇA 17:20~17:40 Secondary prevention for ESUS: Anti-platelets vs NOAC ±ÇÁöÇö(¿ï»ê´ëº´¿ø)
±³À°½Ã°£ 06-29 ¼¼¹Ì³ª½ÇA 17:40~18:00 Dual antiplatelet therapy using cilostazol for high-risk ischemic stroke ±èÁØÅÂ(Àü³²´ëº´¿ø)
±³À°½Ã°£ 06-29 ¼¼¹Ì³ª½ÇA 18:00~18:20 Aspirin for primary prevention of ASCVD Á¤´ÙÀº(¿µ³²´ëº´¿ø)
Åä·Ð 06-29 ¼¼¹Ì³ª½ÇA 18:20~18:40 Panel Discussion and Q & A ÀÌÁØ, ¼Á¤È, ÇÏ»ï¿(¿µ³²´ëº´¿ø(ÀÌÁØ), ºÎ»ê¹éº´¿ø(¼Á¤È), ÇØ¿î´ë¹éº´¿ø(ÇÏ»ï¿))
±âŸ 06-29 ¼¼¹Ì³ª½ÇA 18:40~18:40 Closing remarks ()